샘플 요청 목록

 카트 문의
시장보고서
상품코드
1773936

수의 임상시험 시장

Veterinary Clinical Trials
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 492 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수의 임상시험 세계 시장은 2030년까지 76억 달러에 달할 전망

2024년에 52억 달러로 추정되는 수의 임상시험 세계 시장은 2024년부터 2030년까지 CAGR 6.5%로 성장하여 2030년에는 76억 달러에 달할 것으로 예측됩니다. 이 보고서에서 분석되고 있는 부문 중 하나인 반려동물은 CAGR 5.6%를 기록하며 분석 기간 종료시에는 41억 달러에 달할 것으로 예상됩니다. 축산동물 부문의 성장률은 분석 기간 동안 CAGR 7.3%로 추정됩니다.

미국 시장은 14억 달러로 추정되는 한편 중국은 CAGR 10.0%로 성장할 것으로 예측되는

미국의 수의 임상시험 시장은 2024년에 14억 달러로 추정됩니다. 세계 2위 경제 대국인 중국은 2030년까지 16억 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 10.0%를 기록할 것으로 예상됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있고, 분석 기간 동안 CAGR은 각각 3.3%와 6.3%로 예측됩니다. 유럽에서는 독일이 CAGR 4.3%로 성장할 것으로 예측됩니다.

세계의 수의 임상시험 시장 - 주요 동향과 촉진요인 정리

수의 임상시험이 현대 동물 의학 연구에서 주목받는 이유는 무엇일까?

반려동물과 가축 모두에서 안전하고 효과적이며 근거에 기반한 치료법에 대한 수요가 증가함에 따라 수의 임상시험은 동물 건강 혁신에 필수적인 요소로 자리 잡고 있습니다. 수의학이 복잡하고 고도로 진화하고 인간 건강관리의 진보를 따라잡기 위해 신약, 백신, 생물학적 제제, 의료기기, 치료법을 엄격하고 체계적인 임상시험을 통해 검증할 필요성이 커지고 있습니다. 이러한 임상시험은 시판 전 유효성, 안전성, 투여 프로토콜, 잠재적 부작용을 평가하기 위해 필수적입니다. 반려동물과 가축의 만성질환, 인수공통전염병의 위협, 항균제 내성, 노화와 관련된 증상이 증가함에 따라 새로운 동물용 의약품을 시장에 출시해야 한다는 압박이 커지고 있습니다. 동시에 반려동물 보호자와 가축 생산자 모두 치료 성과 향상을 요구하고 있으며, 정밀 수의학, 맞춤 영양학, 표적 치료제에 대한 관심이 높아지고 있습니다. 이러한 상황의 변화로 인해 CRO, 학술기관, 제약회사, 규제기관 등 많은 기관들이 세계 안전 및 윤리 기준에 부합하는 전임상 및 임상 연구를 중요시하게 되었고, 그 중요성이 그 어느 때보다 커지고 있습니다.

기술이 동물 임상시험의 설계와 수행을 어떻게 강화할 수 있을까?

기술 혁신은 수의 임상시험의 설계, 모니터링 및 분석 방법에 혁명을 일으키고 있습니다. 전자 데이터 수집(EDC) 시스템과 클라우드 기반 시험 관리 플랫폼은 실시간 데이터 수집, 원격 모니터링, 연구기관, 수의사, 스폰서 간의 안전한 데이터 공유를 가능하게 하고 있습니다. 웨어러블 기기 및 센서 기반 목걸이는 현재 심박수, 활동량, 체온 등 시험 중인 동물의 지속적인 생리적 데이터를 수집하는 데 사용되고 있으며, 스트레스를 주지 않고 여러 번 병원을 방문하지 않고도 더 풍부한 인사이트를 제공합니다. AI와 머신러닝 알고리즘은 대규모 데이터세트를 분석하고, 동향을 파악하고, 동물의 품종, 나이, 상태, 위치에 따라 관련 임상시험에 동물을 매칭하여 환자 모집을 개선하기 위해 적용되고 있습니다. 모바일 앱과 원격의료 도구는 특히 장기 만성질환 임상시험에서 가상 진료와 재택 데이터 수집을 지원하고 있습니다. 이러한 디지털 도구는 임상시험의 물류를 간소화하고, 인적 오류를 줄이며, 참가자 유지를 개선하는 데 도움이 되고 있습니다. 전반적으로 이러한 기술은 동물 임상시험의 운영 측면을 최적화할 뿐만 아니라 동물 의학에서 생성되는 과학적 증거의 수준을 높이고 있습니다.

제약사, CRO, 동물병원은 왜 임상시험 활동을 확대하는가?

제약사, 임상시험수탁기관(CRO), 동물병원들은 높아지는 규제 요구사항에 대응하고 동물용 치료제 분야의 혁신을 가속화하기 위해 임상시험 인프라에 대한 투자를 크게 늘리고 있습니다. 동물용 의약품 기업들은 골관절염, 암, 당뇨병, 피부질환, 감염성 질환 등 시장 진입 전 엄격한 임상 검증이 필요한 질환에 대한 특수 제품 개발에 점점 더 집중하고 있습니다. 동물용 의약품 파이프라인이 확대됨에 따라 CRO는 동물병원 및 학술 기관과 협력하여 데이터의 신뢰성과 인구통계학적 다양성을 보장하는 다기관 임상시험을 수행하고 있습니다. 동물병원, 특히 대학 및 대규모 네트워크와 제휴한 동물병원은 환자를 임상시험에 등록하기 위한 연구 부서를 설립하여 반려동물 보호자가 최첨단 치료를 받을 수 있도록 하는 동시에 과학의 발전에 기여하고 있습니다. 또한, 축산농가 및 농업 이해관계자들은 동물용 의약품 기업과 협력하여 가축의 생산성, 질병 저항성 및 식품 안전성을 향상시키는 제품을 시험하고 있습니다. (GCP)에 대한 가이드라인을 강화하여 컴플라이언스 비용을 증가시키고 있지만, 동시에 전체 생태계를 전문화시키고 있습니다. 이러한 협력적이고 구조화된 시험 활동의 급증은 미래 동물용 의약품 솔루션의 기반이 될 데이터 기반 혁신을 수용하는 시장이 성숙해졌음을 반영합니다.

수의 임상시험 시장의 세계 성장 원동력은?

수의 임상시험 시장의 성장은 반려동물 사육 수의 증가, 가축 건강에 대한 우선순위, 규제 진화, 기술 발전과 관련된 여러 가지 상호 연관된 요인에 의해 주도되고 있습니다. 가장 중요한 촉진요인 중 하나는 반려동물의 만성질환과 생활습관병의 확산으로 새로운 치료법과 예방 솔루션에 대한 수요가 증가하고 있다는 점입니다. 한편, 가축의 건강은 특히 신흥 질병, 기후 변화, 항생제 내성에 직면한 상황에서 세계 식량 안보와 지속가능성을 보장하기 위한 최우선 과제로 남아 있습니다. 더 나은 교육, 수의학에 대한 신뢰, 새로운 치료법에 대한 접근성에 힘입어 반려동물 보호자들의 임상 연구 참여에 대한 의지가 높아짐에 따라 연구 참여자 모집과 연구 성공률이 향상되고 있습니다. 동시에, 동물용 의약품 규제 기준의 세계 조화는 제약회사들이 보다 신속한 승인을 촉진하는 국경 간 시험에 대한 투자를 촉진하고 있습니다. 수의학에 특화된 CRO와 디지털 시험 관리 도구의 등장으로 시험의 확장성과 효율성이 향상되어 모든 규모의 클리닉에서 연구에 더 쉽게 접근할 수 있게 되었습니다. 또한, 반려동물 보험, 전문 진료소, 대학 부속 동물병원의 성장으로 계획적이고 대규모 연구를 수행할 수 있는 기회가 증가하고 있습니다. 이러한 일련의 추세는 수의 임상시험을 동물 의료 산업의 중요한 성장 동력으로 바꾸고, 반려동물과 가축, 그리고 그들을 돌보는 수의사들에게 혁신적인 솔루션을 제공하는 데 박차를 가하고 있습니다.

부문

동물(반려동물, 축산동물, 기타 동물), 적응증(종양학, 내과, 정형외과, 심장병학, 신경학, 안과, 피부과, 기타 적응증), 개입(의약품, 의료기기, 기타), 스폰서(제약 및 바이오의약품 기업, 학술 및 연구 센터, 기타)

조사 대상 기업 사례

  • AGLAIA
  • Animal Health Consultants
  • Argenta
  • Biotest Lab
  • Cebiphar
  • Charles River Laboratories
  • Clinvet
  • Cloudbyz
  • ERBC
  • IDEXX Laboratories
  • Inotiv
  • KLIFOVET GmbH
  • knoell
  • Labcorp Drug Development
  • Lohlein & Wolf Vet Research
  • Oncovet Clinical Research(OCR)
  • Premier Research
  • QTest Labs
  • Scantox
  • STATKING Clinical Services

AI 통합

우리는 검증된 전문가 컨텐츠와 AI 툴을 통해 시장 정보와 경쟁 정보를 혁신하고 있습니다.

Global Industry Analysts는 LLM 및 업계 고유의 SLM을 조회하는 일반적인 규범을 따르는 대신 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등 세계 도메인 전문가가 선별한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측하고 있습니다. 이러한 복잡하고 다면적인 시장 역학은 매출원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예상됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

ksm 25.07.28

Global Veterinary Clinical Trials Market to Reach US$7.6 Billion by 2030

The global market for Veterinary Clinical Trials estimated at US$5.2 Billion in the year 2024, is expected to reach US$7.6 Billion by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Companion Animal, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Livestock Animal segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.4 Billion While China is Forecast to Grow at 10.0% CAGR

The Veterinary Clinical Trials market in the U.S. is estimated at US$1.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 10.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 6.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Veterinary Clinical Trials Market - Key Trends & Drivers Summarized

Why Are Veterinary Clinical Trials Gaining Prominence in Modern Animal Health Research?

Veterinary clinical trials are becoming an essential part of animal health innovation, driven by the growing demand for safe, effective, and evidence-based treatments in both companion and livestock animals. As veterinary medicine continues to evolve in complexity and sophistication-mirroring advancements in human healthcare-there is an increasing need to validate new drugs, vaccines, biologics, devices, and therapies through rigorous, structured clinical testing. These trials are critical for assessing efficacy, safety, dosing protocols, and potential side effects before commercial launch. The rise in chronic diseases, zoonotic threats, antimicrobial resistance, and age-related conditions among pets and farm animals is intensifying the pressure to bring new veterinary products to market. At the same time, pet owners and livestock producers alike are seeking improved treatment outcomes, leading to greater interest in precision veterinary medicine, personalized nutrition, and targeted therapeutics. This changing landscape has made veterinary clinical trials more relevant than ever, with a rising number of veterinary research organizations (CROs), academic institutions, pharmaceutical companies, and regulatory agencies placing strong emphasis on preclinical and clinical research that complies with global safety and ethical standards.

How Is Technology Enhancing the Design and Execution of Veterinary Trials?

Technological innovation is revolutionizing how veterinary clinical trials are designed, monitored, and analyzed-making them faster, more data-driven, and compliant with evolving regulations. Electronic data capture (EDC) systems and cloud-based trial management platforms are enabling real-time data collection, remote monitoring, and secure sharing between research sites, veterinarians, and sponsors. Wearable devices and sensor-based collars are now being used to gather continuous physiological data on animals during trials, such as heart rate, activity levels, and body temperature, providing richer insights without causing stress or requiring repeated clinic visits. AI and machine learning algorithms are being applied to analyze large datasets, identify trends, and improve patient recruitment by matching animals to relevant trials based on breed, age, condition, and location. Mobile apps and telemedicine tools are also supporting virtual consultations and at-home data collection, particularly in long-term chronic disease trials. These digital tools are helping streamline trial logistics, reduce human error, and improve participant retention, while also enhancing transparency for pet owners and farm managers. Overall, these technologies are not only optimizing the operational side of veterinary trials but are also raising the standard of scientific evidence generated in veterinary medicine.

Why Are Pharma Companies, CROs, and Veterinary Clinics Expanding Their Clinical Trial Activity?

Pharmaceutical companies, contract research organizations (CROs), and veterinary clinics are significantly expanding their investment in clinical trial infrastructure to meet growing regulatory demands and accelerate innovation in the veterinary therapeutics space. Animal health companies are increasingly focusing on developing specialized products for conditions like osteoarthritis, cancer, diabetes, dermatological disorders, and infectious diseases-areas that require rigorous clinical validation before entering the market. As the veterinary drug pipeline expands, CROs are partnering with veterinary practices and academic institutions to conduct multicenter trials that ensure data reliability and demographic diversity. Veterinary clinics-especially those affiliated with universities or large networks-are establishing research arms to enroll patients in trials, giving pet owners access to cutting-edge treatments while contributing to scientific advancement. Additionally, livestock producers and agribusiness stakeholders are working with animal health companies to test products that improve herd productivity, disease resistance, and food safety. Regulatory bodies such as the FDA (Center for Veterinary Medicine), EMA (CVMP), and other national authorities have strengthened guidance around Good Clinical Practice (GCP) for veterinary studies, which is increasing compliance costs but also professionalizing the entire ecosystem. This surge in collaborative, well-structured trial activity reflects a maturing market that is embracing data-backed innovation as the foundation of future animal health solutions.

What’s Driving the Global Growth of the Veterinary Clinical Trials Market?

The growth in the veterinary clinical trials market is driven by several interrelated factors tied to rising pet ownership, livestock health priorities, regulatory evolution, and technological advancement. One of the most significant drivers is the growing prevalence of chronic and lifestyle-related diseases in companion animals, which has increased demand for new treatment modalities and preventive solutions. Meanwhile, livestock health remains a high priority for ensuring global food security and sustainability, especially in the face of emerging diseases, climate change, and antibiotic resistance. The increasing willingness of pet owners to participate in clinical studies-fueled by better education, trust in veterinary science, and access to novel therapies-is improving recruitment and study success rates. At the same time, global harmonization of regulatory standards for veterinary products is encouraging pharmaceutical companies to invest in cross-border trials that facilitate faster approvals. The rise of veterinary-specific CROs and digital trial management tools is also improving trial scalability and efficiency, making research more accessible to clinics of all sizes. Additionally, the growth of pet insurance, specialty practices, and university-affiliated animal hospitals is creating more opportunities to conduct structured, large-scale research. These collective trends are turning veterinary clinical trials into a critical growth engine for the animal health industry, accelerating the delivery of innovative solutions for pets, livestock, and the veterinarians who care for them.

SCOPE OF STUDY:

The report analyzes the Veterinary Clinical Trials market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Animal (Companion Animal, Livestock Animal, Other Animals); Indication (Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology, Ophthalmology, Dermatology, Other Indication); Intervention (Medicines, Medical Devices, Others); Sponsor (Pharma & Biopharma Companies, Academics & Research Centers, Others)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 48 Featured) -

  • AGLAIA
  • Animal Health Consultants
  • Argenta
  • Biotest Lab
  • Cebiphar
  • Charles River Laboratories
  • Clinvet
  • Cloudbyz
  • ERBC
  • IDEXX Laboratories
  • Inotiv
  • KLIFOVET GmbH
  • knoell
  • Labcorp Drug Development
  • Lohlein & Wolf Vet Research
  • Oncovet Clinical Research (OCR)
  • Premier Research
  • QTest Labs
  • Scantox
  • STATKING Clinical Services

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Veterinary Clinical Trials - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for Evidence-Based Veterinary Medicine Throws the Spotlight on Structured Clinical Research
    • Growth in Companion Animal Therapeutics Strengthens the Business Case for Expanded Trial Activity
    • Here's How Emerging Zoonotic Diseases Are Driving Urgency in Vaccine and Drug Testing for Animal Health
    • Technological Advancements in Remote Monitoring and EDC Systems Accelerate Trial Efficiency and Data Accuracy
    • Expansion of Animal Oncology, Pain Management, and Chronic Disease Segments Spurs Growth in Therapeutic Studies
    • Rising Pet Owner Willingness to Enroll Animals in Trials Expands Participant Pools and Access to Innovation
    • Here's the Story Behind AI and Big Data Enhancing Trial Design, Patient Matching, and Predictive Outcomes
    • Pharmaceutical Investment in Animal-Specific Drug Pipelines Fuels Demand for Clinical Validation Platforms
    • Integration of Biomarkers and Genetic Profiling Drives Precision Veterinary Trial Development
    • Globalization of Veterinary Pharma Markets Encourages Cross-Border Trial Collaborations and Knowledge Sharing
    • Growth of Telemedicine and At-Home Data Collection Tools Broadens Trial Accessibility and Real-World Evidence Capture
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Veterinary Clinical Trials Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Veterinary Clinical Trials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Companion Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Companion Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Companion Animal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Livestock Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Livestock Animal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Livestock Animal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Animals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Animals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Internal Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Internal Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Internal Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Orthopedics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Orthopedics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 38: World Recent Past, Current & Future Analysis for Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 39: World Historic Review for Medicines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: World 15-Year Perspective for Medicines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 41: World Recent Past, Current & Future Analysis for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: World Historic Review for Medical Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: World 15-Year Perspective for Medical Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 44: World Recent Past, Current & Future Analysis for Other Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 45: World Historic Review for Other Interventions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: World 15-Year Perspective for Other Interventions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 47: World Recent Past, Current & Future Analysis for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: World Historic Review for Pharma & Biopharma Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: World 15-Year Perspective for Pharma & Biopharma Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 50: World Recent Past, Current & Future Analysis for Academics & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 51: World Historic Review for Academics & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: World 15-Year Perspective for Academics & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 53: World Recent Past, Current & Future Analysis for Other Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: World Historic Review for Other Sponsors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: World 15-Year Perspective for Other Sponsors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 56: USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: USA Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: USA 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 59: USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: USA Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: USA 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 62: USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: USA Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: USA 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 65: USA Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: USA Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: USA 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 68: Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Canada Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Canada 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 71: Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Canada Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Canada 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 74: Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Canada Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Canada 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 77: Canada Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Canada Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Canada 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • JAPAN
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 80: Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Japan Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Japan 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 83: Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Japan Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Japan 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 86: Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Japan Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Japan 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 89: Japan Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Japan Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Japan 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • CHINA
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 92: China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: China Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: China 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 95: China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: China Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: China 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 98: China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: China Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: China 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 101: China Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: China Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: China 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • EUROPE
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 104: Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Europe Historic Review for Veterinary Clinical Trials by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Europe 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 107: Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Europe Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Europe 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 110: Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Europe Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Europe 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 113: Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Europe Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Europe 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 116: Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Europe Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Europe 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • FRANCE
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 119: France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: France Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: France 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 122: France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: France Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: France 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 125: France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: France Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: France 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 128: France Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: France Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: France 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • GERMANY
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 131: Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Germany Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Germany 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 134: Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Germany Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Germany 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 137: Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Germany Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Germany 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 140: Germany Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Germany Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Germany 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 143: Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Italy Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Italy 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 146: Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Italy Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Italy 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 149: Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Italy Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Italy 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 152: Italy Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Italy Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Italy 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 155: UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: UK Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: UK 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 158: UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: UK Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: UK 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 161: UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: UK Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: UK 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 164: UK Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: UK Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: UK 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 167: Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Spain Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Spain 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 170: Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Spain Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Spain 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 173: Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Spain Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Spain 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 176: Spain Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Spain Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Spain 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 179: Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Russia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Russia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 182: Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Russia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Russia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 185: Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Russia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Russia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 188: Russia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Russia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Russia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 191: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Europe Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Europe Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Europe Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Europe Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Europe Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Europe 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 203: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 204: Asia-Pacific Historic Review for Veterinary Clinical Trials by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 206: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Asia-Pacific Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 209: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Asia-Pacific Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 212: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Asia-Pacific Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 215: Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Asia-Pacific Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 217: Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 218: Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Australia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 220: Australia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 221: Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Australia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 223: Australia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 224: Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Australia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 226: Australia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 227: Australia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Australia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 229: Australia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • INDIA
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 230: India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 231: India Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 232: India 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 233: India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 234: India Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 235: India 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 236: India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 237: India Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 238: India 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 239: India Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 240: India Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 241: India 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 242: South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 243: South Korea Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 244: South Korea 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 245: South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 246: South Korea Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 247: South Korea 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 248: South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 249: South Korea Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 250: South Korea 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 251: South Korea Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 252: South Korea Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 253: South Korea 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 254: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 256: Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 257: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 259: Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 260: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 262: Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 263: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Rest of Asia-Pacific Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 265: Rest of Asia-Pacific 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 266: Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 267: Latin America Historic Review for Veterinary Clinical Trials by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 268: Latin America 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 269: Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Latin America Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 271: Latin America 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 272: Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Latin America Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 274: Latin America 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 275: Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Latin America Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 277: Latin America 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 278: Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Latin America Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 280: Latin America 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 281: Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Argentina Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 283: Argentina 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 284: Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 285: Argentina Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 286: Argentina 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 287: Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 288: Argentina Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 289: Argentina 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 290: Argentina Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 291: Argentina Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 292: Argentina 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 293: Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Brazil Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 295: Brazil 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 296: Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Brazil Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 298: Brazil 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 299: Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Brazil Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 301: Brazil 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 302: Brazil Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Brazil Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 304: Brazil 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 305: Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Mexico Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 307: Mexico 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 308: Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Mexico Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 310: Mexico 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 311: Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 312: Mexico Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 313: Mexico 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 314: Mexico Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 315: Mexico Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 316: Mexico 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 317: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 318: Rest of Latin America Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 319: Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 320: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 321: Rest of Latin America Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 322: Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 323: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 324: Rest of Latin America Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 325: Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 326: Rest of Latin America Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 327: Rest of Latin America Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 328: Rest of Latin America 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 329: Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 330: Middle East Historic Review for Veterinary Clinical Trials by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 331: Middle East 15-Year Perspective for Veterinary Clinical Trials by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 332: Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 333: Middle East Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 334: Middle East 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 335: Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 336: Middle East Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 337: Middle East 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 338: Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 339: Middle East Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 340: Middle East 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 341: Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 342: Middle East Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 343: Middle East 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 344: Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 345: Iran Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 346: Iran 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 347: Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 348: Iran Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 349: Iran 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 350: Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 351: Iran Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 352: Iran 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 353: Iran Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 354: Iran Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 355: Iran 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 356: Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 357: Israel Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 358: Israel 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 359: Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 360: Israel Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 361: Israel 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 362: Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 363: Israel Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 364: Israel 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 365: Israel Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 366: Israel Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 367: Israel 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 368: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 369: Saudi Arabia Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 370: Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 371: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 372: Saudi Arabia Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 373: Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 374: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 375: Saudi Arabia Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 376: Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 377: Saudi Arabia Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 378: Saudi Arabia Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 379: Saudi Arabia 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 380: UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 381: UAE Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 382: UAE 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 383: UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 384: UAE Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 385: UAE 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 386: UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 387: UAE Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 388: UAE 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 389: UAE Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 390: UAE Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 391: UAE 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 392: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 393: Rest of Middle East Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 394: Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 395: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 396: Rest of Middle East Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 397: Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 398: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 399: Rest of Middle East Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 400: Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 401: Rest of Middle East Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 402: Rest of Middle East Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 403: Rest of Middle East 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030
  • AFRICA
    • Veterinary Clinical Trials Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 404: Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 405: Africa Historic Review for Veterinary Clinical Trials by Animal - Companion Animal, Livestock Animal and Other Animals Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 406: Africa 15-Year Perspective for Veterinary Clinical Trials by Animal - Percentage Breakdown of Value Sales for Companion Animal, Livestock Animal and Other Animals for the Years 2015, 2025 & 2030
    • TABLE 407: Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 408: Africa Historic Review for Veterinary Clinical Trials by Indication - Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 409: Africa 15-Year Perspective for Veterinary Clinical Trials by Indication - Percentage Breakdown of Value Sales for Dermatology, Other Indications, Oncology, Internal Medicine, Orthopedics, Cardiology, Neurology and Ophthalmology for the Years 2015, 2025 & 2030
    • TABLE 410: Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 411: Africa Historic Review for Veterinary Clinical Trials by Intervention - Medicines, Medical Devices and Other Interventions Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 412: Africa 15-Year Perspective for Veterinary Clinical Trials by Intervention - Percentage Breakdown of Value Sales for Medicines, Medical Devices and Other Interventions for the Years 2015, 2025 & 2030
    • TABLE 413: Africa Recent Past, Current & Future Analysis for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 414: Africa Historic Review for Veterinary Clinical Trials by Sponsor - Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 415: Africa 15-Year Perspective for Veterinary Clinical Trials by Sponsor - Percentage Breakdown of Value Sales for Pharma & Biopharma Companies, Academics & Research Centers and Other Sponsors for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제